跳至主要内容
临床试验/JPRN-UMIN000013668
JPRN-UMIN000013668已完成未知

Deferred combined androgen blockade therapy using antiandrogen in metastatic prostate cancer patients treated with GnRH antagonist, degarelix - Deferred combined androgen blockade therapy using antiandrogen in metastatic prostate cancer patients treated with GnRH antagonist, degarelix

Department of Urooncology, Saitama Medical University International Medical Center0 个研究点目标入组 70 人开始时间: 2014年4月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1)Patients that correspond to the taboo of the use drug. 2)Patients that had orchidectomy before. 3)Patients younger than 20 years. 4)Active multiple cancer(synchronous multiple cancer/multifocal cancer and metachronous multiple cancer/multifocal cancer with disease free survival is within 5 years except for carcinoma in situ considered as healed or lesion equal to mucosal carcinoma) 5)Active infection requiring systemic therapy 6)Body temperature >=38 degrees Celsius at registration 7)Concomitant psychiatric disease or symptom 8)Continuous systemic steroids or immunosuppressive medication(oral or intravenous) 9)Considered as inadequate by the investigator.

研究者

发起方
Department of Urooncology, Saitama Medical University International Medical Center

相似试验